Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sutro Biopharma (STRO) Shares Issued (2018 - 2025)

Sutro Biopharma (STRO) has disclosed Shares Issued for 8 consecutive years, with $372000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 101.5% to $372000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $372000.0 through Dec 2025, up 100.5% year-over-year, with the annual reading at $372000.0 for FY2025, 37.27% up from the prior year.
  • Shares Issued hit $372000.0 in Q4 2025 for Sutro Biopharma, up from -$246000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $11.7 million in Q4 2023 to a low of -$46.5 million in Q3 2024.
  • Historically, Shares Issued has averaged -$3.1 million across 5 years, with a median of $372000.0 in 2025.
  • Biggest YoY gain for Shares Issued was 1216.46% in 2023; the steepest drop was 2020.43% in 2023.
  • Year by year, Shares Issued stood at $513000.0 in 2021, then crashed by 414.42% to -$1.6 million in 2022, then skyrocketed by 822.69% to $11.7 million in 2023, then plummeted by 312.14% to -$24.7 million in 2024, then soared by 101.5% to $372000.0 in 2025.
  • Business Quant data shows Shares Issued for STRO at $372000.0 in Q4 2025, -$246000.0 in Q2 2025, and $246000.0 in Q1 2025.